A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A TMPRSS2 inhibitor acts as a pan-SARS-CoV-2 prophylactic and therapeutic
Authors
Keywords
-
Journal
NATURE
Volume 605, Issue 7909, Pages 340-348
Publisher
Springer Science and Business Media LLC
Online
2022-03-28
DOI
10.1038/s41586-022-04661-w
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Considerable escape of SARS-CoV-2 Omicron to antibody neutralization
- (2022) Delphine Planas et al. NATURE
- Antibodies elicited by SARS-CoV-2 infection or mRNA vaccines have reduced neutralizing activity against Beta and Omicron pseudoviruses
- (2022) Benjamin L. Sievers et al. Science Translational Medicine
- Evidence of SARS-CoV2 Entry Protein ACE2 in the Human Nose and Olfactory Bulb
- (2021) Moritz Klingenstein et al. CELLS TISSUES ORGANS
- Mechanism of SARS-CoV-2 polymerase stalling by remdesivir
- (2021) Goran Kokic et al. Nature Communications
- Proteolytic Activation of SARS-CoV-2 Spike at the S1/S2 Boundary: Potential Role of Proteases beyond Furin
- (2021) Tiffany Tang et al. ACS Infectious Diseases
- The Variant Gambit: COVID’s Next Move
- (2021) Jessica A. Plante et al. Cell Host & Microbe
- SARS-CoV-2 infection is effectively treated and prevented by EIDD-2801
- (2021) Angela Wahl et al. NATURE
- SARS-CoV-2 dependence on host pathways
- (2021) Jason P. Wong et al. SCIENCE
- Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A
- (2021) Kris M. White et al. SCIENCE
- Intranasal fusion inhibitory lipopeptide prevents direct-contact SARS-CoV-2 transmission in ferrets
- (2021) Rory D. de Vries et al. SCIENCE
- SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development
- (2021) Nicholas Murgolo et al. PLoS Pathogens
- Camostat mesylate inhibits SARS-CoV-2 activation by TMPRSS2-related proteases and its metabolite GBPA exerts antiviral activity
- (2021) Markus Hoffmann et al. EBioMedicine
- Éric Marsault (1971–2021): A Legacy through the Prism of Relationship Chemistry
- (2021) Philippe Sarret JOURNAL OF MEDICINAL CHEMISTRY
- Efficacy of GC-376 against SARS-CoV-2 virus infection in the K18 hACE2 transgenic mouse model
- (2021) C. Joaquín Cáceres et al. Scientific Reports
- The biological and clinical significance of emerging SARS-CoV-2 variants
- (2021) Kaiming Tao et al. NATURE REVIEWS GENETICS
- Postinfection treatment with a protease inhibitor increases survival of mice with a fatal SARS-CoV-2 infection
- (2021) Chamandi S. Dampalla et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A CRISPR/Cas9 genetically engineered organoid biobank reveals essential host factors for coronaviruses
- (2021) Joep Beumer et al. Nature Communications
- Beyond Omicron: what’s next for COVID’s viral evolution
- (2021) Ewen Callaway NATURE
- Mechanisms of SARS-CoV-2 entry into cells
- (2021) Cody B. Jackson et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- A novel class of TMPRSS2 inhibitors potently block SARS-CoV-2 and MERS-CoV viral entry and protect human epithelial lung cells
- (2021) Matthew Mahoney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19
- (2021) Dafydd R. Owen et al. SCIENCE
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- A Multibasic Cleavage Site in the Spike Protein of SARS-CoV-2 Is Essential for Infection of Human Lung Cells
- (2020) Markus Hoffmann et al. MOLECULAR CELL
- Remdesivir for the Treatment of Covid-19 — Preliminary Report
- (2020) John H. Beigel et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- SARS-CoV-2 productively infects human gut enterocytes
- (2020) Mart M. Lamers et al. SCIENCE
- SARS-coronavirus-2 replication in Vero E6 cells: replication kinetics, rapid adaptation and cytopathology
- (2020) Natacha S. Ogando et al. JOURNAL OF GENERAL VIROLOGY
- Intranasal Antiviral Drug Delivery and Coronavirus Disease 2019 (COVID-19): A State of the Art Review
- (2020) Thomas S. Higgins et al. OTOLARYNGOLOGY-HEAD AND NECK SURGERY
- Inhibitors of type II transmembrane serine proteases in the treatment of diseases of the respiratory tract – A review of patent literature
- (2020) Alexandre Murza et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- A painful lesson from the COVID-19 pandemic: the need for broad-spectrum, host-directed antivirals
- (2020) Vipul C. Chitalia et al. Journal of Translational Medicine
- Animal and translational models of SARS-CoV-2 infection and COVID-19
- (2020) M. D. Johansen et al. Mucosal Immunology
- SARS-CoV-2 infection of human ACE2-transgenic mice causes severe lung inflammation and impaired function
- (2020) Emma S. Winkler et al. NATURE IMMUNOLOGY
- High-Content Screening of Eukaryotic Kinase Inhibitors Identify CHK2 Inhibitor Activity Against Mycobacterium tuberculosis
- (2020) Tirosh Shapira et al. Frontiers in Microbiology
- Comparison of Transgenic and Adenovirus hACE2 Mouse Models for SARS-CoV-2 Infection
- (2020) Raveen Rathnasinghe et al. Emerging Microbes & Infections
- The central role of the nasal microenvironment in the transmission, modulation, and clinical progression of SARS-CoV-2 infection
- (2020) Oreste Gallo et al. Mucosal Immunology
- Lethality of SARS-CoV-2 infection in K18 human angiotensin-converting enzyme 2 transgenic mice
- (2020) Fatai S. Oladunni et al. Nature Communications
- Super resolution microscopy and deep learning identify Zika virus reorganization of the endoplasmic reticulum
- (2020) Rory K. M. Long et al. Scientific Reports
- Enteroids Derived From Inflammatory Bowel Disease Patients Display Dysregulated Endoplasmic Reticulum Stress Pathways, Leading to Differential Inflammatory Responses and Dendritic Cell Maturation
- (2019) William D Rees et al. Journal of Crohns & Colitis
- Evaluation of intranasal delivery route of drug administration for brain targeting
- (2018) Franciska Erdő et al. BRAIN RESEARCH BULLETIN
- Modulating the selectivity of matriptase-2 inhibitors with unnatural amino acids
- (2017) Catherine St-Georges et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Airway proteases: an emerging drug target for influenza and other respiratory virus infections
- (2017) Manon Laporte et al. Current Opinion in Virology
- QuPath: Open source software for digital pathology image analysis
- (2017) Peter Bankhead et al. Scientific Reports
- Matriptase Proteolytically Activates Influenza Virus and Promotes Multicycle Replication in the Human Airway Epithelium
- (2013) A. Beaulieu et al. JOURNAL OF VIROLOGY
- Tmprss2 Is Essential for Influenza H1N1 Virus Pathogenesis in Mice
- (2013) Bastian Hatesuer et al. PLoS Pathogens
- SLIC Superpixels Compared to State-of-the-Art Superpixel Methods
- (2012) R. Achanta et al. IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE
- Variability in docking success rates due to dataset preparation
- (2012) Christopher R. Corbeil et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Design and Synthesis of Potent, Selective Inhibitors of Matriptase
- (2012) Éloïc Colombo et al. ACS Medicinal Chemistry Letters
- Human Subtilase SKI-1/S1P Is a Master Regulator of the HCV Lifecycle and a Potential Host Cell Target for Developing Indirect-Acting Antiviral Agents
- (2012) Andrea D. Olmstead et al. PLoS Pathogens
- Probing the substrate specificities of matriptase, matriptase-2, hepsin and DESC1 with internally quenched fluorescent peptides
- (2009) François Béliveau et al. FEBS Journal
- High-throughput quantification of splicing isoforms
- (2009) J.-P. Brosseau et al. RNA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now